Compare MSD & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSD | ANIK |
|---|---|---|
| Founded | 1993 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 134.8M |
| IPO Year | N/A | 1993 |
| Metric | MSD | ANIK |
|---|---|---|
| Price | $7.47 | $9.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 70.2K | ★ 151.0K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 11.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $6.11 | $7.87 |
| 52 Week High | $7.46 | $18.37 |
| Indicator | MSD | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 48.20 |
| Support Level | $7.37 | $9.31 |
| Resistance Level | $7.48 | $9.62 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 90.63 | 35.78 |
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.